-
公开(公告)号:GEP20033130B
公开(公告)日:2003-07-10
申请号:GEAP2000004561
申请日:2000-03-17
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , BADIA MICHAEL , SAUNDERS JEFFREY , RONKIN STIVEN
IPC: C07C275/40 , C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653
Abstract: 1. Technical Result Obtaining new compounds inhibiting IMPDH. 2. Essence The present invention relates to compounds, which inhibit IMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions are particularly well suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH-mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds. 3. Field of Application Medicine.
-
公开(公告)号:AR029341A1
公开(公告)日:2003-06-25
申请号:ARP000101205
申请日:2000-03-17
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , RONKIN STEVEN M , BADIA MICHAEL , SAUNDERS JEFFREY
IPC: C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653 , C07C275/34 , A61K31/277 , A61P37/00
Abstract: Un compuesto inhibidor de la enzima IMPDH que tiene, la formula (A) en donde: cada uno de r1 y R2 es seleccionado independientemente entre hidrogeno; -CF3; -[alquilo(C1-6) de cadena recta o ramificada]; -[alquilo(C1-6) de cadena recta o ramificada]-R7; -[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada]; -[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada]-R7 o ûR7; y en donde al menos uno de R1 o R2 es û[alquilo (C1-6) de cadena recto o ramificada]ûR7; -[alquenilo (c2-6) o alquinilo (C2-6) de cadena recto o ramificada]ûR7 o ûR7 en donde hasta 4 átomos de hidrogeno en cualquiera de dichos alquilo, alquenilo o alquinilo son opcionalmente e independientemente reemplazados por R3; y en donde uno o ambos de R1 o R2 son esterificados opcionalmente para formar una prodroga; o en donde R1 y R2 alternativamente forman conjuntamente tetrahidrofuranilo, en donde R9 es hidrogeno, (R)-metilo, (R)-etilo o (R)-hidroximetilo, un átomo de hidrogeno en dicho tetrahidrofurano es reemplazado por ûOR6 o ûR7 y en donde R9 es (S)ûmetilo, (S)-etilo o (S)-hidroximetilo , un átomo de hidrogeno en dicho tetrahidrofurano es reemplazado opcionalmente por ûOR6 o -R7, en donde si R9 es hidrogeno, (R)-metilo, (R)-etilo o (R)-hidroximetilo y cada uno de R1 y R2 son independientemente hidrogeno, -[alquilo(C1-6) no sustituido de cadena recta o ramificada], o -[alquenilo(C2-6) o alquinilo (C2-6) no sustituidos de cadena recta o ramificada], entonces la porcion del compuesto representada por ûCH(R1)R2 es un alquilo (C5-12), alquenilo (C5-12) o alquinilo (C5-12) de cadenas rectas o ramificadas; cada R3 es seleccionado independientemente entre halo, CH, -OR4 o ûN(R5)2; R4 es seleccionado entre hidrogeno, -[alquilo(C1-6) de cadena recta o ramificada], -[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada], [alquilo (C2-6) de cadena recta o ramificada]-R7, -[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada]-R7, -C(O)-[alquilo (C1-6) de cadena recta o ramificada] ûC(O)-[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada], -C(O)-[alquilo(C1-6) de cadena recta o ramificada]-N(R8)2, -C(O)-[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada]-N(R8)2, -P(O)(OR8)2, -P(O)(OR8)(R8), -C(O)-R7, -S(O)2N(R5)2, -[alquilo(C1-6) de cadena recta o ramificada]ûCN, o -[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada]-CN; Cada R5 es seleccionado independientemente entre hidrogeno, -[alquilo (C1-6) de cadena recta o ramificada], -[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada], -[alquilo (C1-6) de cadena recta o ramificada]-R7, -[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada ]-R7, -[alquilo (C1-6) de cadena recta o ramificada] ûR7, -[alquilo (C1-6) de cadena recta o ramificada]ûCN, -[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada]-CN, -[alquilo(C1-6) de cadena recta o ramificada]-OR4, -[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada]ûOR4, -C(O)-[alquilo (C1-6) de cadena recta o ramificada], -C(O)-[alquenilo (C2-6) o alquinilo (C2-6) de cadena recta o ramificada], -C(O)-R7, -C(O)O-R7,-C(O)O- [alquilo(C1-6) de cadena recta o ramificada], -C(O)O-[alquenilo(C2-6) o alquinilo(C2-6) de cadena recta o ramificada], -S(O)2-[alquilo(C1-6) de cadena recta o ramificada], o ûS(O)2-R7; o dos porciones R5, si están ligados al mismo átomo de nitrogeno, forman conjuntamente con dicho átomo de nitrogeno un anillo heterocíclico de 3 a 7 miembros, en donde dicho anillo heterocíclico contiene opcionalmente 1 a 3 heteroátomos adicionales seleccionados independientemente de N; O, S, S(O)2; R6 es seleccionado entre ûC(O)-CH3, CH2-C(O)-OH, -CH2-C(O)-O-tBu, -CH2-CN o CH2-CsCH; cada R7 es un sistema anular monocíclico o bicíclico, en donde en dicho sistema anular: i) cada anillo comprende 3 a 7 átomos en el anillo seleccionado independientemente entre C, N, O o S; ii) no más de 4 átomos del anillo son seleccionados entre N, O o S; iii) cualquier CH2 es reemplazado opcionalmente con C(O); iv) cualquier S es reemplazado opcionalmente con S(O) o S(O)2; cada R8 es seleccionado independientemente entre hidrogeno o û [alquilo(C1-4) de cadena o ramificada]; en donde en cualquier sistema anular en dicho compuesto hasta 3 átomos de hidrogeno ligados a los átomos del anillo son reemplazados opcionalmente e independientemente con halo, hidroxi, nitro, ciano, amino, -[alquilo (C1-4) de cadena recta o ramificada]; o-[alquilo (C1-4) de cadena recta o ramificada], -[alquenilo (C2-4) o alquinilo (C2-4) de cadena recta o ramificada], o O-[alquenilo(C2-6) o alquinilo (C2-4) de cadena recata o ramificada]; y en donde cualquier sistema anular es opcionalmente benzofusionado; R9 es seleccionado entre hidrogeno, (R)-metilo, (S)-metilo, (R)-etilo, (S)ûetilo, (R)-hidroximetilo o (S)-hidroximetilo; R10 es seleccionado entre ûCsN o 5 oxazolilo; y R11 es seleccionado entre halo, -O-[alquilo (C1-3) de cadena recta o ramificada] o ûO-[alquenilo (C2-3) o alquinilo(C2-3) de cadena recta o ramificada].
-
公开(公告)号:EE200100492A
公开(公告)日:2002-12-16
申请号:EEP200100492
申请日:2000-03-17
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , BADIA MICHAEL , SAUNDERS JEFFREY
IPC: C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653 , A61K31/277 , C07C275/34
Abstract: The present invention relates to compounds which inhibit JMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting JMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH-mediated processes. This invention also relates to methods for inhibiting the activity of I1VIPDH using the compounds of this invention and related compounds.
-
公开(公告)号:CA2433197A1
公开(公告)日:2002-08-08
申请号:CA2433197
申请日:2001-12-12
Applicant: VERTEX PHARMA
Inventor: CHARIFSON PAUL , STAMOS DEAN , LIAO YUSHENG , GRILLOT ANNE-LAURE , BADIA MICHAEL , TRUDEAU MARTIN
IPC: C07D235/32 , A61K31/00 , A61K31/4184 , A61K31/423 , A61K31/4245 , A61K31/437 , A61K31/4412 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/4709 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K45/06 , A61P31/00 , A61P31/04 , A61P43/00 , C07D213/00 , C07D221/00 , C07D235/00 , C07D235/30 , C07D263/58 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/04 , C07D405/14 , C07D409/04 , C07D413/04 , C07D471/04 , C07D471/14 , C07D491/04 , C07D491/056 , C07D498/04 , C07D521/00 , C07F9/6558 , C07F9/6561
Abstract: The present invention relates to compounds of the formula (I): or a pharmaceutically acceptable derivative or prodrug thereof. The compounds are useful as inhibitors of bacterial gyrase activity. The present invention als o relates to methods for treating bacterial infections in mammals. The present invention also relates to methods for decreasing bacterial quantity in a biological sample.
-
公开(公告)号:TR200103428T2
公开(公告)日:2002-04-22
申请号:TR200103428
申请日:2000-03-17
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , BADIA MICHAEL , SAUNDERS JEFFREY
IPC: C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653 , A61K31/277 , C07C275/34
Abstract: The present invention relates to compounds which inhibit JMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting JMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH-mediated processes. This invention also relates to methods for inhibiting the activity of I1VIPDH using the compounds of this invention and related compounds.
-
公开(公告)号:AU3757700A
公开(公告)日:2000-10-09
申请号:AU3757700
申请日:2000-03-17
Applicant: VERTEX PHARMA
Inventor: STAMOS DEAN , TRUDEAU MARTIN , BETHIEL SCOTT , BADIA MICHAEL , SAUNDERS JEFFREY
IPC: C07D307/20 , A61K31/27 , A61K31/275 , A61K31/341 , A61K31/421 , A61K31/422 , A61K31/454 , A61K31/5377 , A61K31/541 , A61K45/00 , A61P1/18 , A61P9/10 , A61P11/06 , A61P19/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/02 , A61P43/00 , C07C275/40 , C07C275/42 , C07D263/32 , C07D413/12 , C07D417/12 , C07F9/653 , A61K31/277 , C07C275/34
Abstract: The present invention relates to compounds which inhibit JMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting JMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH-mediated processes. This invention also relates to methods for inhibiting the activity of I1VIPDH using the compounds of this invention and related compounds.
-
公开(公告)号:SI3330255T1
公开(公告)日:2021-03-31
申请号:SI201032047
申请日:2010-03-19
Applicant: VERTEX PHARMA
Inventor: DEMATTEI JOHN , LOOKER ADAM R , NEUBERT-LANGILLE BOBBIANNA , TRUDEAU MARTIN , ROPER STEFANIE , RYAN MICHAEL , YAP DAHRIKA MILFRED LAO , KRUEGER BRIAN R , GROOTENHUIS PETER D J , VAN GROOR FREDERICK F , BOTFIELD MARTYN C , ZLOKARNIK GREGOR
IPC: C07D215/00 , C07C229/00
-
公开(公告)号:SI3219705T1
公开(公告)日:2020-08-31
申请号:SI200632370
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
IPC: C07D215/00 , A61K31/00
-
公开(公告)号:RS60205B1
公开(公告)日:2020-06-30
申请号:RSP20200487
申请日:2006-12-28
Applicant: VERTEX PHARMA
Inventor: HURTER PATRICIA , GONG YUCHUAN , YOUNG CHRISTOPHER R , CONNELLY PATRICK , ROWE WILLIAM , COSTACHE ADRIANA , KRAWIEC MARIUSZ , FENG YUSHI , TRUDEAU MARTIN
IPC: C07D215/56 , A61K31/445
-
公开(公告)号:AU2018204671B2
公开(公告)日:2019-05-02
申请号:AU2018204671
申请日:2018-06-27
Applicant: VERTEX PHARMA
Inventor: GROOTENHUIS PETER D J , VAN GOOR FREDRICK F , BOTFIELD MARTYN C , ZLOKARNIK GREGOR , DEMATTEI JOHN , LOOKER ADAM R , NEUBERT-LANGILLE BOBBIANNA J , TRUDEAU MARTIN , ROEPER STEFANIE , RYAN MICHAEL P , YAP GUERETTE DAHRIKA MILFRED LAO , KRUEGER BRIAN R
IPC: C07D215/233
Abstract: The invention provides a process for the preparation of a compound of Formula 1, N H (Rx-X Formula 1 comprising coupling a carboxylic acid of Formula 2 (Rx-X OH Formula 2 with an aniline of Formula 3 Formula 3 in the presence of a coupling agent.
-
-
-
-
-
-
-
-
-